201 related articles for article (PubMed ID: 34953406)
1. Tumor budding to investigate local invasion, metastasis and prognosis in temporal bone squamous cell carcinoma.
Alessandrini L; Zanoletti E; Cazzador D; Sbaraglia M; Franz L; Tealdo G; Frigo AC; Blandamura S; Nicolai P; Mazzoni A; Marioni G
Pathol Res Pract; 2022 Jan; 229():153719. PubMed ID: 34953406
[TBL] [Abstract][Full Text] [Related]
2. Temporal bone carcinoma: a first glance beyond the conventional clinical and pathological prognostic factors.
Marioni G; Martini A; Favaretto N; Franchella S; Cappellesso R; Marino F; Blandamura S; Mazzoni A; Zanoletti E
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):2903-10. PubMed ID: 26518208
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S
Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595
[TBL] [Abstract][Full Text] [Related]
4. Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion.
Shimizu S; Miyazaki A; Sonoda T; Koike K; Ogi K; Kobayashi JI; Kaneko T; Igarashi T; Ueda M; Dehari H; Miyakawa A; Hasegawa T; Hiratsuka H
PLoS One; 2018; 13(4):e0195451. PubMed ID: 29672550
[TBL] [Abstract][Full Text] [Related]
5. Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
Giger OT; Comtesse SC; Lugli A; Zlobec I; Kurrer MO
Mod Pathol; 2012 Jul; 25(7):1048-53. PubMed ID: 22481282
[TBL] [Abstract][Full Text] [Related]
6. Recurrent squamous cell carcinoma of the temporal bone: critical analysis of cases with a poor prognosis.
Zanoletti E; Marioni G; Franchella S; Lovato A; Giacomelli L; Martini A; Mazzoni A
Am J Otolaryngol; 2015; 36(3):352-5. PubMed ID: 25595048
[TBL] [Abstract][Full Text] [Related]
7. Relaxin-2 expression in temporal bone carcinoma.
Marioni G; Zanoletti E; Lovato A; Franchella S; Giacomelli L; Gianatti A; Mazzoni A; Blandamura S; Martini A
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3225-32. PubMed ID: 25388992
[TBL] [Abstract][Full Text] [Related]
8. Temporal Bone Squamous Cell Carcinoma: Molecular Markers Involved in Carcinogenesis, Behavior, and Prognosis: A Systematic Review.
Alessandrini L; Astolfi L; Franz L; Gentilin E; Mazzoni A; Zanoletti E; Marioni G
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562926
[TBL] [Abstract][Full Text] [Related]
9. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral budding: A novel prognostic biomarker for tumor recurrence and a potential predictor of nodal metastasis in uterine cervical cancer.
Chong GO; Jee-Young Park N; Han HS; Cho J; Kim MG; Choi Y; Yeo JY; Lee YH; Hong DG; Park JY
Eur J Surg Oncol; 2021 Dec; 47(12):3182-3187. PubMed ID: 34284905
[TBL] [Abstract][Full Text] [Related]
11. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
12. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
[TBL] [Abstract][Full Text] [Related]
13. Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.
Arora A; Husain N; Bansal A; Neyaz A; Jaiswal R; Jain K; Chaturvedi A; Anand N; Malhotra K; Shukla S
Am J Surg Pathol; 2017 Jul; 41(7):950-960. PubMed ID: 28346327
[TBL] [Abstract][Full Text] [Related]
14. Tumor Budding and Worse Pattern of Invasion Can Predict Nodal Metastasis in Oral Cancers and Associated With Poor Survival in Early-Stage Tumors.
Chatterjee D; Bansal V; Malik V; Bhagat R; Punia RS; Handa U; Gupta A; Dass A
Ear Nose Throat J; 2019 Aug; 98(7):E112-E119. PubMed ID: 31072197
[TBL] [Abstract][Full Text] [Related]
15. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of temporal bone squamous cell carcinoma: A single-institution experience.
Zheng Y; Qiu K; Fu Y; Yang W; Cheng D; Rao Y; Mao M; Song Y; Xu W; Ren J; Zhao Y
Cancer Med; 2023 Mar; 12(5):5304-5311. PubMed ID: 36229984
[TBL] [Abstract][Full Text] [Related]
17. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
Thies S; Guldener L; Slotta-Huspenina J; Zlobec I; Koelzer VH; Lugli A; Kröll D; Seiler CA; Feith M; Langer R
Hum Pathol; 2016 Jun; 52():1-8. PubMed ID: 26980046
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for treating temporal bone carcinoma based on long-term outcomes.
Bacciu A; Clemente IA; Piccirillo E; Ferrari S; Sanna M
Otol Neurotol; 2013 Jul; 34(5):898-907. PubMed ID: 23507994
[TBL] [Abstract][Full Text] [Related]
19. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma.
Kristensen GB; Abeler VM; Risberg B; Trop C; Bryne M
Gynecol Oncol; 1999 Aug; 74(2):245-51. PubMed ID: 10419739
[TBL] [Abstract][Full Text] [Related]
20. Cortactin and phosphorylated cortactin tyr
Marioni G; Zanoletti E; Mazzoni A; Gianatti A; Valentini E; Girasoli L; Guariento M; Giacomelli L; Martini A; Blandamura S
Am J Otolaryngol; 2017; 38(2):208-212. PubMed ID: 28131549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
